Olema Oncology
The Associate Director, GMP Quality will oversee GMP activities for Olema Oncology's clinical and commercial products, focusing on small molecule drug substance manufacturing, analytical review, and supplier compliance. The role involves cross‑functional collaboration with CMC, Regulatory, and Supply Chain teams, as well as representing the company during inspections and submissions.
Headquarters
San Francisco, California, United States
Company Size
51-200 employees
Founded
2007
Olema Oncology is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel targeted therapies for metastatic breast cancer and beyond. The company leverages its deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance to advance its pipeline, including Phase 3 breast cancer trials and a KAT6 inhibitor program being evaluated in solid tumors and prostate cancer. Founded in 2006 and headquartered in San Francisco, California, Olema trades on Nasdaq under the ticker OLMA.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Olema Oncology.
13% below the average for this role
Olema Oncology to Present at the TD Cowen 46th Annual Health Care Conference
3 weeks ago
Senior Specialist, GMP Quality Assurance
kaileratherapeutics
Senior Director, Regulatory CMC
Eli Lilly and Company
Senior Director, GMP Quality Assurance
Beeline Medicines
Director, ADC CMC Sciences
AbbVie
Associate Director, GMP Quality Assurance
Revolution Medicines
Senior Director of Analytical Development
Centessa Pharmaceuticals